Cargando…

Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy: the Lung PLUS study

INTRODUCTION: To better understand the impact of stereotactic body radiotherapy (SBRT) and its treatment-related toxicity on early-stage non-small cell lung cancer (ES-NSCLC) patients, we conducted the Lung PLUS study in a real-world setting. METHODS: This is a monocentric prospective longitudinal s...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Weijst, Lotte, Bultijnck, Renée, Van Damme, Axel, Huybrechts, Vincent, van Eijkeren, Marc, Lievens, Yolande
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485838/ https://www.ncbi.nlm.nih.gov/pubmed/37692843 http://dx.doi.org/10.3389/fonc.2023.1220248

Ejemplares similares

Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study
por: Van Der Weijst, Lotte, et al.
Publicado: (2021)

Neurocognitive functioning following lung cancer treatment: The PRO-Long Study
por: van der Weijst, Lotte, et al.
Publicado: (2022)

Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review
por: Van Der Weijst, Lotte, et al.
Publicado: (2019)

Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021)

Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
por: Spaas, Mathieu, et al.
Publicado: (2019)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020)

Changes in pulmonary function and their correlation with dose–volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer
por: Takemoto, Shinya, et al.
Publicado: (2021)

A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters
por: Luo, Li-Mei, et al.
Publicado: (2022)

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
por: Peters, Cedric, et al.
Publicado: (2021)

Stereotactic body radiotherapy in lung cancer: an update
por: Abreu, Carlos Eduardo Cintra Vita, et al.
Publicado: (2015)

Harmonization of dose prescription for lung stereotactic radiotherapy
por: Beldjoudi, Guillaume, et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI
por: Chen, Guofu, et al.
Publicado: (2019)

Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at risk
por: Johnston, Noémie, et al.
Publicado: (2022)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
por: Finazzi, Tobias, et al.
Publicado: (2020)

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
por: Mercier, Carole, et al.
Publicado: (2019)

Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies
por: Kim, Yeon Joo, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
por: Kang, Kylie H., et al.
Publicado: (2015)

Stability of percutaneously implanted markers for lung stereotactic radiotherapy
por: Persson, Gitte F., et al.
Publicado: (2013)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
por: Lindsay, Adam D., et al.
Publicado: (2018)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
por: Gutiérrez, Enrique, et al.
Publicado: (2021)

Effect of stereotactic radiotherapy on immune microenvironment of lung cancer
por: Xiao, Yao, et al.
Publicado: (2022)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
por: Ricco, Anthony, et al.
Publicado: (2017)

Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
por: Benzaquen, Jonathan, et al.
Publicado: (2023)

Peripheral memory and naïve T cells in non-small cell lung cancer patients with lung metastases undergoing stereotactic body radiotherapy: predictors of early tumor response
por: Liu, Chao, et al.
Publicado: (2019)

Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
por: Taremi, Mojgan, et al.
Publicado: (2012)

Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors
por: Watanabe, Meguru, et al.
Publicado: (2013)

Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung
por: Ochiai, Satoru, et al.
Publicado: (2016)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
por: Inoue, Tetsuya, et al.
Publicado: (2012)

Efficacy and tolerability of stereotactic body radiotherapy for lung metastases in three patients with pediatric malignancies
por: Deck, Jared, et al.
Publicado: (2019)

Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity
por: Onishi, Hiroshi, et al.
Publicado: (2020)

Stereotactic radiotherapy for brain metastases in patients with lung cancer; outcome and toxicity in clinical practice
por: Gunnarsson, Kerstin, et al.
Publicado: (2022)

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
por: Van Assche, Katrijn, et al.
Publicado: (2014)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
por: Chen, Hanbo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_of6smjjftdcaml4bfn9uc0163f